Sensor-based cell and tissue screening for personalized cancer chemotherapy

Personalized tumor chemotherapy depends on reliable assay methods, either based on molecular “predictive biomarkers” or on a direct, functional ex vivo assessment of cellular chemosensitivity. As a member of the latter category, a novel high-content platform is described monitoring human mamma carcinoma explants in real time and label-free before, during and after an ex vivo modeled chemotherapy. Tissue explants are sliced with a vibratome and laid into the microreaction chambers of a 24-well sensor test plate. Within these ≈23 μl volume chambers, sensors for pH and dissolved oxygen record rates of cellular oxygen uptake and extracellular acidification. Robot-controlled fluid system and incubation are parts of the tissue culture maintenance system while an integrated microscope is used for process surveillance. Sliced surgical explants from breast cancerous tissue generate well-detectable ex vivo metabolic activity. Metabolic rates, in particular oxygen consumption rates have a tendency to decrease over time. Nonetheless, the impact of added drugs (doxorubicin, chloroacetaldehyde) is discriminable. Sensor-based platforms should be evaluated in explorative clinical studies for their suitability to support targeted systemic cancer therapy. Throughput is sufficient for testing various drugs in a range of concentrations while the information content obtained from multiparametric real-time analysis is superior to conventional endpoint assays.

[1]  D. Demetrick,et al.  Targeting cancer treatment: the challenge of anatomical pathology to the analytical chemist. , 2003, The Analyst.

[2]  J. W. Parce,et al.  Biosensors based on the energy metabolism of living cells: the physical chemistry and cell biology of extracellular acidification. , 1992, Biosensors & bioelectronics.

[3]  Robert A. Weinberg,et al.  Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.

[4]  Andrea Morguet,et al.  A New Method to Assess Drug Sensitivity on Breast Tumor Acute Slices Preparation , 2006, Annals of the New York Academy of Sciences.

[5]  R. Larsson,et al.  Microphysiometry: new technology for evaluation of anticancer drug activity in human tumor cells in vitro , 1998, Anti-cancer drugs.

[6]  A. Tomida,et al.  Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. , 1999, Anti-cancer drug design.

[7]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[8]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[9]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[10]  Andrea Morguet,et al.  The Bionas technology for anticancer drug screening , 2009, Expert opinion on drug discovery.

[11]  D. Grundl,et al.  Finite Element Modelling of Microphysiometry on Cellular Specimen , 2009 .

[12]  Robert A Nagourney,et al.  Ex vivo programmed cell death and the prediction of response to chemotherapy , 2006, Current treatment options in oncology.

[13]  Min Wu,et al.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. , 2007, American journal of physiology. Cell physiology.

[14]  J. McAlpine,et al.  Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays. , 2008, Gynecologic oncology.

[15]  Nils Cordes,et al.  Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.

[16]  Saumyadipta Pyne,et al.  Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors , 2010, Proceedings of the National Academy of Sciences.

[17]  B Wolf,et al.  Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay , 2001, Anti-cancer drugs.

[18]  A. Hamburger,et al.  Primary bioassay of human tumor stem cells. , 1977, Science.

[19]  J. Hilfrich,et al.  Towards in-vitro prediction of an in-vivo cytostatic response of human tumor cells with a fast chemosensitivity assay. , 2001, Toxicology.

[20]  Rustum Ym,et al.  Predictive tests for cancer chemotherapy and the problem of tumor cell heterogeneity. , 1988 .

[21]  C. Graham,et al.  Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity. , 2007, Experimental cell research.

[22]  J O Barentsz,et al.  Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. , 2009, Cancer treatment reviews.

[23]  Ralf Ehret,et al.  Microsensor-Aided Measurements of Cellular Signalling and Metabolism on Tumor Cells , 1998, Tumor Biology.

[24]  Robert A Gatenby,et al.  Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. , 2008, Seminars in cancer biology.

[25]  M. Volm,et al.  Clinical relevance of predictive tests for cancer chemotherapy. , 1982, Cancer treatment reviews.

[26]  U Abel,et al.  Chemotherapy of advanced epithelial cancer--a critical review. , 1992, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  B Wolf,et al.  Functional cellular assays with multiparametric silicon sensor chips. , 2003, Lab on a chip.

[28]  Gooitzen M van Dam,et al.  Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate. , 2009, Medical hypotheses.

[29]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[30]  D. Gewirtz,et al.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. , 1999, Biochemical pharmacology.

[31]  F. Hafner,et al.  Cytosensor Microphysiometer: technology and recent applications. , 2000, Biosensors & bioelectronics.

[32]  Robert J Gillies,et al.  Glycolysis in cancer: a potential target for therapy. , 2007, The international journal of biochemistry & cell biology.